Security key
92673K108
Vigil Neuroscience, Inc. - Common Stock (VIGL)
CUSIP: 92673K108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 46,698,729
- Total 13F shares
- 26,133,344
- Share change
- -360,092
- Total reported value
- $104,533,282
- Price per share
- $4.00
- Number of holders
- 57
- Value change
- -$712,116
- Number of buys
- 31
- Number of sells
- 31
Report period
Q2 2024
Institutions
57
Top holders
10
VIGL full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Vigil Neuroscience, Inc. SEC filings
Vigil Neuroscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92673K108
Recent filing periods:
Top shareholders of VIGL - Vigil Neuroscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
12%
|
5,836,874
|
$19,903,740 | — | 31 Mar 2024 | |
| Northpond Ventures, LLC |
13F
|
Company |
9%
|
4,214,498
|
$14,371,438 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
4.6%
|
2,165,811
|
$7,385,416 | — | 31 Mar 2024 | |
| BVF INC/IL |
13F
|
Company |
3.9%
|
1,813,633
|
$6,184,489 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
3.9%
|
1,811,191
|
$6,176,161 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
3.7%
|
1,730,414
|
$5,900,712 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.4%
|
1,594,931
|
$5,438,715 | — | 31 Mar 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
2.1%
|
994,900
|
$3,392,609 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.1%
|
980,311
|
$3,342,861 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.9%
|
894,473
|
$3,050,152 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.9%
|
877,032
|
$2,990,680 | — | 31 Mar 2024 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
1.2%
|
560,595
|
$1,911,629 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1%
|
471,958
|
$1,609,377 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.96%
|
448,891
|
$1,530,718 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.72%
|
334,242
|
$1,139,878 | — | 31 Mar 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.62%
|
289,460
|
$987,059 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.61%
|
286,063
|
$975,475 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.49%
|
228,674
|
$779,778 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
138,720
|
$473,035 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.24%
|
113,036
|
$385,453 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.15%
|
71,815
|
$244,889 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.14%
|
67,310
|
$229,527 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
59,964
|
$204,000 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
57,964
|
$197,657 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
45,750
|
$156,007 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.1%
|
44,998
|
$153,443 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
41,968
|
$143,111 | — | 31 Mar 2024 | |
| PEAK6 Investments LLC |
13F
|
Company |
0.09%
|
41,486
|
$141,467 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.07%
|
33,368
|
$234,911 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.07%
|
33,129
|
$112,970 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.06%
|
26,840
|
$91,524 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.05%
|
24,100
|
$82,181 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
23,362
|
$79,665 | — | 31 Mar 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
20,377
|
$69,486 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.04%
|
19,178
|
$65,397 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
18,939
|
$64,582 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
18,239
|
$62,195 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
17,953
|
$61,212 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
16,151
|
$55,075 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
10,140
|
$34,577 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.02%
|
7,919
|
$27,004 | — | 31 Mar 2024 | |
| STRS OHIO |
13F
|
Company |
0.02%
|
7,700
|
$26,000 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
7,116
|
$24,266 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
5,789
|
$19,740 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
5,655
|
$19,284 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
1,650
|
$5,627 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,554
|
$5,268 | — | 31 Mar 2024 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
1,327
|
$4,525 | — | 31 Mar 2024 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
542
|
$2,000 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
360
|
$1,000 | — | 31 Mar 2024 |
Institutional Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q2 2024
As of 30 Jun 2024,
Vigil Neuroscience, Inc. - Common Stock (VIGL) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,133,344 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, Northpond Ventures, LLC, Artal Group S.A., BVF INC/IL, SPHERA FUNDS MANAGEMENT LTD., Point72 Asset Management, L.P., CITADEL ADVISORS LLC, 683 Capital Management, LLC, VANGUARD GROUP INC, and STEMPOINT CAPITAL LP.
This page lists
57
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
51
Q2 2024 holders
57
Holder diff
6
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.